Top News: Pandora Media Inc (NYSE:P), Avon Products Inc. (NYSE:AVP), AT&T, Inc. (NYSE:T), Facebook Inc (NASDAQ:FB), Alcoa Inc. (NYSE:AA)

Pandora Media Inc (NYSE:P) CRO John Trimble sold 40,000 shares of Pandora Media stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $23.48, for a total transaction of $939,200.00. Following the completion of the transaction, the executive now directly owns 113,067 shares of the company’s stock, valued…

Read More

Momentum Stocks : Peabody Energy Corp. (NYSE:BTU), Goldcorp Inc. (NYSE:GG), S&T Bancorp Inc. (NASDAQ:STBA), Iteris, Inc. (NYSEMKT:ITI), Bristow Group, Inc. (NYSE:BRS)

Peabody Energy Corp. (NYSE:BTU) has lodged an application with the New South Wales government to extend underground operations at its Hunter Valley coal mine. The application for the Wambo mine near Singleton proposes development of an additional longwall panel for the existing North Wambo underground. An extra 2 million t of coal would be extracted…

Read More

Don’t Miss : Chesapeake Energy Corporation (NYSE:CHK), Anadarko Petroleum Corporation (NYSE:APC), American Railcar Industries, Inc. (NASDAQ:ARII), Ford Motor Company (NYSE:F), BONT

Chesapeake Energy Corporation (NYSE:CHK) has undergone a radical transformation since CEO Doug Lawler joined the company last summer. Lawler said Chesapeake’s success is no accident, built on newly established core values that include trust, respect and integrity. Chesapeake Energy Corporation (NYSE:CHK) belongs to Basic Materials sector. Its net profit margin is 2.60% and weekly performance…

Read More
Biotechnology Stockmarket Biotech

Sunesis Pharmaceuticals Stock Down : Biotech Trial Failure

Shares of Sunesis Pharmaceuticals, Inc (SNSS) plunged significantly after the company announced that its phase III trial, VALOR, failed to meet its primary endpoint. The randomized, double-blind, placebo-controlled trial (n=711) evaluated the efficacy of Qinprezo (vosaroxin) and cytarabine in patients suffering from first relapsed or refractory acute myeloid leukemia (AML). The trial failed to reach…

Read More